Follow-up of an asymptomatic Chagas disease population of children after treatment with nifurtimox (Lampit) in a sylvatic endemic transmission area of Colombia.
<h4>Background</h4>Chagas disease is an anthropozoonosis caused by Trypanosoma cruzi. Two drugs are currently used for the etiological treatment of the disease: Nifurtimox (Lampit) and Benznidazole. This study presents a quasi-experimental trial (non-control group) of sixty-two patients...
Saved in:
| Main Authors: | Fiorella Bianchi, Zulma Cucunubá, Felipe Guhl, Nadia Lorena González, Hector Freilij, Rubén Santiago Nicholls, Juan David Ramírez, Marleny Montilla, Astrid Carolina Flórez, Fernando Rosas, Victor Saavedra, Nubia Silva |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2015-02-01
|
| Series: | PLoS Neglected Tropical Diseases |
| Online Access: | https://journals.plos.org/plosntds/article/file?id=10.1371/journal.pntd.0003465&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Development and Characterization of Innovative Nifurtimox Formulations as Therapeutic Alternative for Chagas Disease
by: Ana Lia Mazzeti, et al.
Published: (2025-02-01) -
Negligible exposure to nifurtimox through breast milk during maternal treatment for Chagas Disease.
by: Samanta Moroni, et al.
Published: (2019-08-01) -
Redefining the treatment of Chagas disease: a review of recent clinical and pharmacological data for a novel formulation of nifurtimox.
by: Jaime Altcheh, et al.
Published: (2025-02-01) -
Trypanosoma cruzi infection follow-up in a sylvatic vector of Chagas disease: Comparing early and late stage nymphs.
by: Valeria Cortés, et al.
Published: (2021-09-01) -
Biologic and Genetics Aspects of Chagas Disease at Endemic Areas
by: Marilanda Ferreira Bellini, et al.
Published: (2012-01-01)